| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,612 |
1,468 |
$111K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,809 |
1,806 |
$111K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
778 |
773 |
$70K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,895 |
1,732 |
$60K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
58 |
58 |
$24K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
406 |
390 |
$20K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
94 |
93 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
182 |
177 |
$7K |
| 99215 |
Prolong outpt/office vis |
74 |
71 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
84 |
84 |
$6K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
15 |
15 |
$4K |
| 87634 |
|
75 |
75 |
$3K |
| 99001 |
|
243 |
224 |
$3K |
| 99000 |
|
340 |
329 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
178 |
86 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
89 |
84 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
117 |
113 |
$1K |
| 81002 |
|
314 |
303 |
$767.16 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
18 |
18 |
$585.84 |
| 36415 |
Collection of venous blood by venipuncture |
14 |
12 |
$49.63 |
| 85018 |
|
14 |
12 |
$22.07 |
| 85014 |
|
14 |
12 |
$22.06 |
| 99072 |
|
3,195 |
2,925 |
$0.00 |
| 99051 |
|
878 |
850 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
13 |
12 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
51 |
51 |
$0.00 |